Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

May 17, 2013
To include Crohn's disease in GLPG0634 program   Read More »
May 17, 2013
Will leverage chemical and biological expertise   Read More »
May 16, 2013
RYI-008 has the potential to treat autoimmune diseases and cancer   Read More »
May 16, 2013
Expands portfolio of safety assessment services to the Japanese market   Read More »
May 15, 2013
AbbVie gains option to acquire ALV003 assets or equity   Read More »
May 14, 2013
CMC will use CHEF1 system for cell line development   Read More »
May 10, 2013
Will use immune assay to identify biomarkers in cells of cancer patients   Read More »
May 9, 2013
Forest will have the option to exclusively license heart drug   Read More »
May 9, 2013
Will use ATMI’s SUB technology   Read More »
May 8, 2013
Partnership aims to increase yields and reduce production costs   Read More »
May 8, 2013
To provide regulatory consulting and product registration services   Read More »
May 6, 2013
Will develop test to screen for mCRC   Read More »
May 6, 2013
Will commit resources to global Oraxol, Oratecan   Read More »
May 3, 2013
Will use Ambrx's protein med-chem tech   Read More »
May 2, 2013
Will combine methods for diabetes data collection   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On